eBC and mBC Treatment | KISQALI® (ribociclib)
KISQALI is a prescription medicine used to treat adults with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer: in combination with an aromatase inhibitor for stage II and III early breast cancer with a high risk of coming back.
Metastatic Breast Cancer | KISQALI® (ribociclib)
Learn about HR+, HER2- metastatic breast cancer treatment in premenopausal and postmenopausal women with KISQALI. See full Prescribing & Safety Info.
How KISQALI® (ribociclib) Works | mBC
Learn how KISQALI can work as a possible HR+, HER2- metastatic breast cancer treatment combined with hormone therapy. See full Prescribing & Safety Info.
Clinical Trial Results | mBC | KISQALI® (ribociclib)
People with HR+, HER2- metastatic breast cancer (mBC) were treated with KISQALI in multiple studies. In each study, the goal was to determine if KISQALI + hormone therapy could help people live longer than hormone therapy alone.
Frequently Asked Questions | mBC | KISQALI® (ribociclib)
KISQALI is a prescription medicine used to treat adults with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer that has gotten worse or has spread to other parts of the body (advanced …
Side Effects | mBC | KISQALI® (ribociclib)
The most common side effects from the clinical trials were generally mild to moderate and included: decreased white blood cell counts. decreased red blood cell counts. increased liver function tests. infections. nausea. increased kidney …
Dosing & Administration | mBC | KISQALI® (ribociclib)
Learn more about the dosing and administration of KISQALI for metastatic breast cancer in combination with a hormone therapy. See full Prescribing & Safety Info.
Early Breast Cancer Treatment (eBC) | KISQALI® (ribociclib)
Learn more about KISQALI, a treatment option for early breast cancer (eBC) used in combination with a hormone therapy. See full Prescribing and Safety Info.
Helpful Patient Resources | mBC | KISQALI® (ribociclib)
Read and download helpful patient resource materials about metastatic breast cancer and treatment with KISQALI. See full Prescribing & Safety Information.
Novartis Patient Support - KISQALI
Call Novartis Patient Support at 1-866-433-8000, Monday-Friday, 8:00 AM to 8:00 PM ET, excluding holidays. Learn more about Novartis Patient Support for KISQALI® (ribociclib) and access available financial support resources. See full Prescribing and Safety Info.